PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 224 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $4,848,000 | +420.7% | 269,462 | +685.0% | 0.27% | +478.3% |
| Q2 2019 | $931,000 | +14.9% | 34,328 | +47.0% | 0.05% | 0.0% |
| Q1 2019 | $810,000 | -73.2% | 23,350 | -79.4% | 0.05% | -73.7% |
| Q3 2018 | $3,019,000 | +80.1% | 113,350 | +155.5% | 0.18% | +65.1% |
| Q2 2018 | $1,676,000 | +18522.2% | 44,372 | +23628.3% | 0.11% | +10500.0% |
| Q4 2017 | $9,000 | -10.0% | 187 | -1.6% | 0.00% | 0.0% |
| Q3 2017 | $10,000 | -28.6% | 190 | -23.1% | 0.00% | 0.0% |
| Q2 2017 | $14,000 | -67.4% | 247 | -77.5% | 0.00% | -75.0% |
| Q1 2017 | $43,000 | -65.6% | 1,100 | -75.0% | 0.00% | -77.8% |
| Q4 2014 | $125,000 | – | 4,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 270,832 | $6,467,000 | 5.27% |
| Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
| Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
| First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
| SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
| Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
| HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |